OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Seventh Annual Needham & Company, LLC Biotechnology & Medical Technology Conference in New York City. The conference will be simultaneously webcast over the Internet.
Mr. Michels is scheduled to speak on June 11, 2008, at approximately 11:00 am Eastern Time (8:00 am Pacific Time). Interested investors can access the live audio webcast of the presentation by going to OraSure Technologies’ web site, www.orasure.com, and clicking on the Investor Info link. A replay of the audio webcast will be available on OraSure Technologies’ web site for seven days. Alternatively, you can access the live audio webcast of the presentation via the following link http://www.wsw.com/webcast/needham18/osur/.
About OraSure Technologies
OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, and commercial and industrial entities.
OraSure Technologies is the leading supplier of oral-fluid collection devices to the life insurance industry and public health markets for the detection of antibodies to HIV. In addition, the Company supplies oral-fluid testing solutions for drugs of abuse testing. For more information on the Company, please go to www.orasure.com.
Contacts:
Company contact:
Ronald H. Spair
Chief
Financial Officer
610-882-1820
Investorinfo@orasure.com
www.orasure.com
